CARBONARA, S. The efficacy of dalbavancin and impact on hospitalization and treatment costs in patients with ABSSSI. Global and Regional Health Technology Assessment, [S. l.], v. 11, n. Suppl. 2, p. 13–17, 2024. DOI: 10.33393/grhta.2024.3045. Disponível em: https://journals.aboutscience.eu/index.php/grhta/article/view/3045. Acesso em: 12 sep. 2024.